z-logo
open-access-imgOpen Access
First Molecular Report of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) guyanensis in Paraguayan Inhabitants Using High-Resolution Melt-PCR
Author(s) -
Oscar Daniel Salvioni Recalde,
José Pereira Brunelli,
Míriam Rolón,
Antonieta Rojas de Árias,
Olga Aldama,
Celeste Vega Gómez
Publication year - 2019
Publication title -
american journal of tropical medicine and hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.015
H-Index - 151
eISSN - 1476-1645
pISSN - 0002-9637
DOI - 10.4269/ajtmh.18-0880
Subject(s) - leishmania braziliensis , leishmaniasis , leishmania infantum , cutaneous leishmaniasis , leishmania , mucocutaneous zone , biology , kinetoplastida , polymerase chain reaction , amastigote , virology , pathology , microbiology and biotechnology , visceral leishmaniasis , medicine , immunology , disease , parasite hosting , protozoal disease , gene , genetics , world wide web , computer science , malaria
American tegumentary leishmaniasis is an endemic anthropozoonosis undergoing expansion on the American continent. The disease is caused by several Leishmania species and it is manifested as cutaneous and mucocutaneous leishmaniasis. In this study, we evaluate the viability of high-resolution melt polymerase chain reaction (HRM-PCR) analysis to differentiate four closely related Leishmania species as a routine tool for the diagnosis of leishmaniasis. For this purpose, biopsy specimens from cutaneous and mucocutaneous lesions were taken from 132 individuals from endemic and non-endemic areas for leishmaniasis. Each sample was processed for parasitological, histopathological, and molecular analysis. Positive biopsy samples were analyzed by HRM-PCR of a 144-bp heat-shock protein (hsp70) gene fragment, and new cases were confirmed by sequencing. Of the 132 samples analyzed, 36 (27%) were positive for Leishmania spp., of which 86% were from cutaneous lesions and 14% from mucocutaneous lesions. We identified Leishmania ( Viannia ) braziliensis (84%), Leishmania ( Leishmania ) infantum (13%), and Leishmania ( Leishmania ) amazonensis (3%) in cutaneous lesions, and L. ( V. ) braziliensis (40%), L. ( L. ) infantum (20%), L. ( L. ) amazonensis (20%), and Leishmania ( Viannia ) guyanensis (20%) in mucocutaneous lesions. The main purpose of this research was to report for the first time in Paraguay the presence of L. ( L. ) amazonensis and L. ( V. ) guyanensis in patients with cutaneous and mucocutaneous lesions, using the HRM-PCR technique. In addition, we report the presence of additional new cases of L. ( L. ) infantum in cutaneous lesions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom